Lyell Immunopharma, Inc. (LYEL) (CIK 0001806952) (LYEL)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jul. 17, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jul. 17, 2026 | CORRESP | Neutral/Informational | Moderate | Lyell Immunopharma, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by July 21, 202… | Read Filing EDGAR |
| Jul. 16, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has notified Lyell Immunopharma, Inc. that it will not review their registration statement filed on July 13, 2026. The correspondence emphasizes that the responsibility fo… | Read Filing EDGAR |
| Apr. 13, 2026 | CORRESP | Neutral/Informational | Moderate | Lyell Immunopharma, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by April 14, 20… | Read Filing EDGAR |
| Apr. 8, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Lyell Immunopharma, Inc. that it will not review their registration statement filed on April 3, 2026. The SEC emphasizes that the responsibility for th… | Read Filing EDGAR |
| Dec. 11, 2025 | CORRESP | Neutral/Informational | Moderate | Lyell Immunopharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. They are seeking to have the ef… | Read Filing EDGAR |